Page last updated: 2024-08-16

ribavirin and Alopecia Circumscripta

ribavirin has been researched along with Alopecia Circumscripta in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Markulin, A; Morović, M; Patrk, I; Patrk, J1
Borum, ML; Igiehon, E; Shafa, S1
Agesta, N; Díaz-Pérez, JL; Zabala, R1
Alpat, SN; Kartal, ED; Ozgunes, I; Usluer, G1

Other Studies

4 other study(ies) available for ribavirin and Alopecia Circumscripta

ArticleYear
Cutaneous reactions in patients with chronic hepatitis C treated with peginterferon and ribavirin.
    Dermatology (Basel, Switzerland), 2014, Volume: 228, Issue:1

    Topics: Adult; Age Factors; Alopecia Areata; Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Eczema; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Prospective Studies; Pruritus; Recombinant Proteins; Ribavirin; Time Factors

2014
A case of irreversible alopecia associated with ribavirin and peg-interferon therapy.
    European journal of gastroenterology & hepatology, 2010, Volume: 22, Issue:1

    Topics: Aged; Alopecia Areata; Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2010
Alopecia areata during interferon alpha-2b/ribavirin therapy.
    Dermatology (Basel, Switzerland), 2002, Volume: 205, Issue:3

    Topics: Alopecia Areata; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Middle Aged; Ribavirin

2002
Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection.
    European journal of gastroenterology & hepatology, 2007, Volume: 19, Issue:9

    Topics: Adult; Alopecia Areata; Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2007